1 / 5

Hyperhidrosis Treatment Market

Hyperhidrosis Treatment Market<br>

swati15
Download Presentation

Hyperhidrosis Treatment Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hyperhidrosis Hyperhidrosis Treatment Market Treatment Market Share, Industry Share, Industry Analysis And Analysis And Segment Forecasts, Segment Forecasts, 2020 2020 – – 2027 2027

  2. Market Market Summary Summary The global hyperhidrosis treatment market size is estimated to reach USD 2.10 Billion from USD 1.27 Billion in 2019, delivering a CAGR of 5.7% through 2027. The market growth is driven by increasing awareness regarding hyperhidrosis treatment. The prevalence rate of hyperhidrosis is increasing globally. The prevalence rate of the disorder in the U.S. was around 5% in 2017, and more than half of the cases registered were of axillary hyperhidrosis. The number of treatment options for treating this condition is increasing and can be adopted as per the severity of the disease. Several regional governments are updating reimbursement implications for hyperhidrosis treatment. For instance, in 2019, the United States began a ICD-10-CM reimbursement scheme code for operating procedures and medications in hyperhidrosis cases. Growing awareness regarding the types of treatment alternatives available for managing severe perspiration to improve the quality of life is poised to boost hyperhidrosis treatment industry growth in the coming years. Antiperspirants, botox injections, and anticholinergics are some of the commonly used treatments for excessive sweating. In 2016, a product for permanent treatment of excessive armpit sweating called miraDry was launched. Botox injection by Allergan is the only FDA approved injection for primary focal hyperhidrosis treatment. The growing interest of industry leaders in developing excessive perspiration related treatment and enhanced research & development funding is projected to supplement hyperhidrosis treatment share through 2027. To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report- detail/hyperhidrosis-treatment-market

  3. Market Market Summary Summary Further key findings from the report suggest On the basis of end-use, the hospitals & clinics segment held a major chunk of the hyperhidrosis market share in 2019 and is estimated to register a CAGR of 5.5% through 2027. The segmental growth can be attributed to factors like well-resourced diagnostic rooms, better health coverage for healthcare services, and the availability of highly skilled healthcare professionals. In the regional landscape, North America remains the key revenue-generating region for the secondary generalized hyperhidrosis treatment market. In 2018, the region accounted for a whopping USD 388.7 million revenue share and is forecast to gain major traction over the analysis period. The regional growth can be attributed to the availability of state-of-art technologies, favorable reimbursement scenarios, a paradigm shift towards precision medicine, and rising awareness regarding excessive sweating treatment. The Asia-Pacific region is anticipated to contribute significantly to the global generalized hyperhidrosis treatment market with a CAGR of 6.2% through 2027. The regional growth is a result of increased investment by the biotechnology and pharmaceutical companies in hyperhidrosis research. Key players in the global hyperhidrosis treatment market are Allergan (Ireland), Dermira, Inc. (U.S), Brickell Biotech, Inc. (U.S), GlaxoSmithKline plc (UK), Ulthera, Inc. (U.S), TheraVida, Sientra Inc. (U.S), Revance Therapeutics , Inc. (U.S), and Dr. August Wolff GmbH (Germany), among others.

  4. Market Market Summary Summary For the purpose of this report, Reports and Data has segmented the Global Hyperhidrosis Treatment market on the basis of disease type, treatment type, distribution channel, and region: Disease type Outlook (Revenue in Million USD; 2016–2026) Primary Focal Hyperhidrosis Palmar Hyperhidrosis Plantar Hyperhidrosis Others Treatment Type Outlook (Revenue in Million USD; 2016–2026) Medications Antiperspirants Prescription strength antiperspirants Over-the-counter antiperspirants Anticholinergics Botox (botulinum toxin) – A Distribution Channel (Revenue in Million USD; 2016–2026) Hospital Pharmacy Retail Pharmacy Online Prescription Stores

  5. About US About US Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact US Contact US John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related